HK2 and colorectal cancer: Worenine, an alkaloid from Coptis chinensis Franch., targets HIF1α to decrease glycolytic activity and downregulate the expression of glycolytic enzymes (PFK-L, HK2, and PKM2), thereby inhibiting colorectal cancer cell growth, proliferation, and cell cycle progression [155].